| Medicare NCD | NCD 220.6.10 - FDG PET for Breast Cancer (Replaced with Section 220.6.17) - RETIRED | 2010-05-01 |
| Medicare NCD | NCD 220.6.4 - FDG PET for Colorectal Cancer (Replaced with Section 220.6.17) - RETIRED | 2010-05-01 |
| Medicare NCD | NCD 220.6.3 - FDG PET for Esophageal Cancer (Replaced with Section 220.6.17) - RETIRED | 2010-05-01 |
| Medicare NCD | NCD 220.6.7 - FDG PET for Head and Neck Cancers (Replaced with Section 220.6.17) - RETIRED | 2010-05-01 |
| Medicare NCD | NCD 220.6.2 - FDG PET for Lung Cancer (Replaced with Section 220.6.17) - RETIRED | 2010-05-01 |
| Medicare NCD | NCD 220.6.5 - FDG PET for Lymphoma (Replaced with Section 220.6.17) - RETIRED | 2010-05-01 |
| Medicare NCD | NCD 220.6.6 - FDG PET for Melanoma (Replaced with Section 220.6.17) - RETIRED | 2010-05-01 |
| Medicare NCD | NCD 220.6.12 - FDG PET for Soft Tissue Sarcoma (Replaced with Section 220.6.17) - RETIRED | 2010-05-01 |
| Medicare NCD | NCD 220.6.11 - FDG PET for Thyroid Cancer (Replaced with Section 220.6.17) - RETIRED | 2010-05-01 |
| Sunshine Health Clinical Policy | Fecal Calprotectin Assay | 2010-04-01 |